期刊文献+

阿托伐他汀治疗心脏功能不全的疗效观察

Clinical Observation of Atorvastatin Treatment of Cardiac Dysfunction
下载PDF
导出
摘要 目的探讨他汀类药物在心功能不全患者的治疗方面的作用。方法 62例心功能不全的患者随机分为两组,对照组进行强心、利尿、ACEI以及β-受体阻滞剂等常规性治疗,治疗组则于以上治疗的同时给予阿托伐他汀每日10mg。研究治疗后3个月的心功能分级,同时注意患者的高敏C-反应蛋白改变。结果治疗组比对照组3个月后心功能改善明显,高敏C反应蛋白下降明显(P<0.05)。结论阿托伐他汀能够改善心功能不全,减少高敏C反应蛋白。 Objective To study the statin drugs in the treatment of patients with cardiac dysfunction roles. Methods Sixty-two examples cardiac insufficiency patients were randomly divided into two groups, the control groups were given the strong heart, diuresis, ACEI and beta blockers routine treatment, the treatment group was above treatment at the same time to give atorvastatin daily 10mg. After treatment three months, simuhaneouslys to pay attention patients grading cardiac function, high sensitirity-C reactive protein change. Results Treatment group than the control group three months turned their hearts function improved, high sensitivity-C reactive protein down significantly ( P 〈 0.05 ). Conclusion Atorvastatin can improve cardiac insufficiency, reduce gao min c-reactive protein.
出处 《中国现代医生》 2011年第23期159-160,共2页 China Modern Doctor
基金 浙江省金华市2010年度科学技术研究计划项目(计划编号:2010-3-028)
关键词 阿托伐他汀 心功能不全 高敏-C反应蛋白 Atorvastatin Cardiac insufficiency High sensitivity C-reactive protein
  • 相关文献

参考文献7

二级参考文献31

  • 1马义平,廖东承,田武生.阿托伐他汀治疗对慢性心衰患者心功能和细胞因子的影响[J].临床医学,2006,26(5):11-12. 被引量:4
  • 2田美蓉,李莉,赵碧琼,刘小坤.阿托伐他汀对心肌肥厚致心衰患者心功能的影响[J].山东医药,2006,46(31):64-64. 被引量:1
  • 3杨涛,赵季红.阿托伐他汀对介入术后的冠心病慢性心衰患者预后的影响[J].武警医学院学报,2007,16(3):249-251. 被引量:7
  • 4正宗译.NSAID和他汀类药联用可能有防结肠癌作用[J].中国医学论坛报,1999,25(29):7-7.
  • 5Node K, Fujita M, Kitakaze M, et al. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy[J].Circulation,2003,108(7):839-853.
  • 6Plaquett RU, Cornish KG, Zucker IH, et al. Statin therapy restores sympathovagal balance in experimental heart failure[J].J Appl Physiol,2003,95 (2):700-704.
  • 7Khush KK, Waters DD, Bittner V, et al. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the TNT study[J]. Circulation,2007,115(5):576-583.
  • 8Vitol S, Angelin B, Juliusson G. Simvastafin impairs mitogen-induced proliferation of malignant B - Lymphocytes from humansin vivo and in vitro studies. Lipids, 1997, 32(3) :255.
  • 9Clutterbuck RD, Millar BC, Powles RL, et al. Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice. Br J Haematol, 1998, 102(2):522.
  • 10Arita S, Une S, Ohtsuka S, et al. Prevention of primary islet isogrft nonfunction in mice with pravastatin. Transplantation, 1998, 65(11) :1429.

共引文献2434

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部